Natasa Gisev

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 36

Top Topics

Top Venues

British journal of clinical pharmacology

Drug and alcohol review

International journal of clinical pharmacy

This page only lists publications with an associated author ORCID identifier.

Publications

Chrianna Bharat, Ria E Hopkins, Mark S Chambers, Louisa Degenhardt, Amy Peacock, Michael Farrell, Wing See Yuen, Nicola Wing Young Man, Natasa Gisev
Age, period, and cohort trends of substance poisoning, alcohol-related disease, and suicide deaths in Australia, 1980-2019. Social psychiatry and psychiatric epidemiology (2024)
Helga Zoega, Michael O Falster, Malcolm Bjørn Gillies, Melisa Litchfield, Ximena Camacho, Claudia Bruno, Benjamin Daniels, Natasha Donnolley, Alys Havard, Andrea L Schaffer, Georgina M Chambers, Louisa Degenhardt, Timothy A Dobbins, Natasa Gisev, Rebecca Q Ivers, Louisa R Jorm, Bette Liu, Claire M Vajdic, Sallie-Anne Pearson
The Medicines Intelligence Data Platform: A Population-Based Data Resource From New South Wales, Australia. Pharmacoepidemiology and drug safety 33 (8) (2024)
Malcolm Bjørn Gillies, Kendal Chidwick, Chrianna Bharat, Ximena Camacho, David Currow, Natasa Gisev, Louisa Degenhardt, Sallie-Anne Pearson
Long-term prescribed opioid use after hospitalization or emergency department presentation among opioid naïve adults (2014-2020)-A population-based descriptive cohort study. British journal of clinical pharmacology (2024)
Ria E Hopkins, Gabrielle Campbell, Louisa Degenhardt, Natasa Gisev
'We didn't cause the opioid epidemic': The experiences of Australians prescribed opioids for chronic non-cancer pain at a time of increasing restrictions. Drug and alcohol review 43 (6) (2024)
Ria E Hopkins, Gabrielle Campbell, Louisa Degenhardt, Natasa Gisev
'We didn't cause the opioid epidemic': The experiences of Australians prescribed opioids for chronic non-cancer pain at a time of increasing restrictions. Drug and alcohol review (2024)
Malcolm Bjørn Gillies, Ximena Camacho, Chrianna Bharat, Luke Buizen, Fiona Blyth, David Currow, Andrew Wilson, Louisa Degenhardt, Natasa Gisev, Sallie-Anne Pearson
Oxycodone initiation in Australia (2014-2018): Sociodemographic factors and preceding health service use. British journal of clinical pharmacology 90 (7) (2024)
Malcolm Bjørn Gillies, Kendal Chidwick, Chrianna Bharat, Ximena Camacho, David Currow, Natasa Gisev, Louisa Degenhardt, Sallie-Anne Pearson
Long-term prescribed opioid use after hospitalization or emergency department presentation among opioid naïve adults (2014-2020)-A population-based descriptive cohort study. British journal of clinical pharmacology 90 (9) (2024)
Malcolm Bjørn Gillies, Kendal Chidwick, Chrianna Bharat, Ximena Camacho, David Currow, Natasa Gisev, Louisa Degenhardt, Sallie-Anne Pearson
Long-term prescribed opioid use after hospitalization or emergency department presentation among opioid naïve adults (2014-2020)-A population-based descriptive cohort study. British journal of clinical pharmacology 90 (9) (2024)
Malcolm Bjørn Gillies, Ximena Camacho, Chrianna Bharat, Luke Buizen, Fiona Blyth, David Currow, Andrew Wilson, Louisa Degenhardt, Natasa Gisev, Sallie-Anne Pearson
Oxycodone initiation in Australia (2014-2018): Sociodemographic factors and preceding health service use. British journal of clinical pharmacology (2024)
Natasa Gisev, Sallie-Anne Pearson, Timothy Dobbins, Luke Buizen, Thomas Murphy, Andrew Wilson, Fiona Blyth, Adrian Dunlop, Sarah Larney, David C Currow, Richard P Mattick, Louisa Degenhardt
Cohort profile: POPPY II - a population-based cohort examining the patterns and outcomes of prescription opioid use in New South Wales, Australia. BMJ open 13 (5) (2023)
Duha N Gide, Sarira El-Den, Yee Lam Elim Lee, Natasa Gisev, Kevin Ou, Claire L O'reilly
Community pharmacists' acceptability of pharmacist-delivered depression screening for older adults: a qualitative study. International journal of clinical pharmacy (2023)
Duha N Gide, Sarira El-Den, Yee Lam Elim Lee, Natasa Gisev, Kevin Ou, Claire L O'reilly
Community pharmacists' acceptability of pharmacist-delivered depression screening for older adults: a qualitative study. International journal of clinical pharmacy (2023)
Duha N Gide, Sarira El-Den, Yee Lam Elim Lee, Natasa Gisev, Kevin Ou, Claire L O'reilly
Community pharmacists' acceptability of pharmacist-delivered depression screening for older adults: a qualitative study. International journal of clinical pharmacy (2023)
Wubshet Hailu Tesfaye, Ines Krass, Kamal Sud, David W Johnson, Connie Van, Vincent Lawrence Versace, Rita McMorrow, Judith Fethney, Judy Mullan, Anh Tran, Breonny Robson, Sanjyot Vagholkar, Lukas Kairaitis, Natasa Gisev, Mariam Fathima, Vivien Tong, Natali Coric, Ronald Lynel Castelino
Impact of a pharmacy-led screening and intervention in people at risk of or living with chronic kidney disease in a primary care setting: a cluster randomised trial protocol. BMJ open 13 (12) (2023)
Wubshet Hailu Tesfaye, Ines Krass, Kamal Sud, David W Johnson, Connie Van, Vincent Lawrence Versace, Rita McMorrow, Judith Fethney, Judy Mullan, Anh Tran, Breonny Robson, Sanjyot Vagholkar, Lukas Kairaitis, Natasa Gisev, Mariam Fathima, Vivien Tong, Natali Coric, Ronald Lynel Castelino
Impact of a pharmacy-led screening and intervention in people at risk of or living with chronic kidney disease in a primary care setting: a cluster randomised trial protocol. BMJ open 13 (12) (2023)
Natasa Gisev, Sallie-Anne Pearson, Timothy Dobbins, Luke Buizen, Thomas Murphy, Andrew Wilson, Fiona Blyth, Adrian Dunlop, Sarah Larney, David C Currow, Richard P Mattick, Louisa Degenhardt
Cohort profile: POPPY II - a population-based cohort examining the patterns and outcomes of prescription opioid use in New South Wales, Australia. BMJ open 13 (5) (2023)
Wubshet Hailu Tesfaye, Ines Krass, Kamal Sud, David W Johnson, Connie Van, Vincent Lawrence Versace, Rita McMorrow, Judith Fethney, Judy Mullan, Anh Tran, Breonny Robson, Sanjyot Vagholkar, Lukas Kairaitis, Natasa Gisev, Mariam Fathima, Vivien Tong, Natali Coric, Ronald Lynel Castelino
Impact of a pharmacy-led screening and intervention in people at risk of or living with chronic kidney disease in a primary care setting: a cluster randomised trial protocol. BMJ open 13 (12) (2023)
Duha N Gide, Sarira El-Den, Yee Lam Elim Lee, Natasa Gisev, Kevin Ou, Claire L O'reilly
Community pharmacists' acceptability of pharmacist-delivered depression screening for older adults: a qualitative study. International journal of clinical pharmacy (2023)
Alys Havard, Nicola R Jones, Chrianna Bharat, Natasa Gisev, Sallie-Anne Pearson, Anthony Shakeshaft, Michael Farrell, Louisa Degenhardt
Mortality during and after specialist alcohol and other drug treatment: Variation in rates according to principal drug of concern and treatment modality. Drug and alcohol review (2023)
Natasa Gisev, Sallie-Anne Pearson, Timothy Dobbins, Luke Buizen, Thomas Murphy, Andrew Wilson, Fiona Blyth, Adrian Dunlop, Sarah Larney, David C Currow, Richard P Mattick, Louisa Degenhardt
Cohort profile: POPPY II - a population-based cohort examining the patterns and outcomes of prescription opioid use in New South Wales, Australia. BMJ open 13 (5) (2023)
Wubshet Hailu Tesfaye, Ines Krass, Kamal Sud, David W Johnson, Connie Van, Vincent Lawrence Versace, Rita McMorrow, Judith Fethney, Judy Mullan, Anh Tran, Breonny Robson, Sanjyot Vagholkar, Lukas Kairaitis, Natasa Gisev, Mariam Fathima, Vivien Tong, Natali Coric, Ronald Lynel Castelino
Impact of a pharmacy-led screening and intervention in people at risk of or living with chronic kidney disease in a primary care setting: a cluster randomised trial protocol. BMJ open 13 (12) (2023)
Andrea L Schaffer, Natasa Gisev, Fiona M Blyth, Nicholas Alan Buckley, David Christopher Currow, Timothy A Dobbins, Andrew Wilson, Louisa Degenhardt, Sallie-Anne Pearson
Opioid prescribing patterns among medical practitioners in New South Wales, Australia. Drug and alcohol review (2023)
Wing See Yuen, Janni K Y Leung, Nicola Wing Young Man, Vivian Chiu, Natasa Gisev, Michael Livingston, Louisa Degenhardt, Michael Farrell, Sallie-Anne Pearson, Timothy Dobbins, Melissa A Jackson, Richard P Mattick, Amy Peacock
Age at first alcohol-related hospital separation or emergency department presentation and rate of re-admission: A retrospective data linkage cohort of young Australians. Drug and alcohol review 41 (7) (2022)
Chrianna Bharat, Louisa Degenhardt, Sallie-Anne Pearson, Luke Buizen, Andrew Wilson, Timothy Dobbins, Natasa Gisev
A data-informed approach using individualised dispensing patterns to estimate medicine exposure periods and dose from pharmaceutical claims data. Pharmacoepidemiology and drug safety (2022)
Juliana de Oliveira Costa, Claudia Bruno, Navya Baranwal, Natasa Gisev, Timothy A Dobbins, Louisa Degenhardt, Sallie-Anne Pearson
Variations in Long-term Opioid Therapy Definitions: A Systematic Review of Observational Studies Using Routinely Collected Data (2000-2019). British journal of clinical pharmacology 87 (10) (2021)
Suzanne Nielsen, Natasa Gisev, Janni Leung, Philip James Clare, Raimondo Bruno, Nicholas Lintzeris, Briony Larance, Fiona Blyth, Wayne Hall, Milton Cohen, Louisa Degenhardt, Michael Farrell, Gabrielle Campbell
Clinical correlates and outcomes associated with pregabalin use among people prescribed opioids for chronic non-cancer pain: A five-year prospective cohort study. British journal of clinical pharmacology 87 (8) (2021)
Shafkat Rahman, Alex Trussell, Sallie-Anne Pearson, Nicholas A Buckley, Emily A Karanges, Rose Cairns, Melisa Litchfield, Adam Todd, Natasa Gisev
Trends in transdermal fentanyl utilisation and fatal fentanyl overdose across Australia (2003-2015). Drug and alcohol review (2021)
Chrianna Bharat, Sarah Larney, Sebastiano Barbieri, Timothy A Dobbins, Nicola R Jones, Matthew Hickman, Natasa Gisev, Robert Ali, Louisa Degenhardt
The effect of person, treatment and prescriber characteristics on retention in opioid agonist treatment: a 15-year retrospective cohort study. Addiction (Abingdon, England) 116 (11) (2021)
Rachel Sutherland, Paul M Dietze, Natasa Gisev, Raimondo Bruno, Gabrielle Campbell, Sonja Memedovic, Amy Peacock
Patterns and correlates of prescribed and non-prescribed pregabalin use among a sample of people who inject drugs in Australia. Drug and alcohol review 39 (5) (2020)
Thomas Santo, Briony Larance, Raimondo Bruno, Natasa Gisev, Suzanne Nielsen, Louisa Degenhardt, Gabrielle Campbell
Correlates of indicators of potential extra-medical opioid use in people prescribed opioids for chronic non-cancer pain. Drug and alcohol review 39 (2) (2019)
Amy Peacock, Vivian Chiu, Janni Leung, Timothy Dobbins, Sarah Larney, Natasa Gisev, Sallie-Anne Pearson, Louisa Degenhardt
Protocol for the Data-Linkage Alcohol Cohort Study (DACS): investigating mortality, morbidity and offending among people with an alcohol-related problem using linked administrative data. BMJ open 9 (8) (2019)
Natasa Gisev, Jonathan Brett, Amy Peacock
Extra-medical use of antipsychotics: what can be learnt from experiences with other prescription medicines? Addiction (Abingdon, England) 115 (7) (2019)
Natasa Gisev, Sallie-Anne Pearson, Timothy Dobbins, David C Currow, Fiona Blyth, Sarah Larney, Adrian Dunlop, Richard P Mattick, Andrew Wilson, Louisa Degenhardt
Combating escalating harms associated with pharmaceutical opioid use in Australia: the POPPY II study protocol. BMJ open 8 (12) (2018)
Natasa Gisev, Sallie-Anne Pearson, Briony Larance, Sarah Larney, Bianca Blanch, Louisa Degenhardt
A population-based study of transdermal fentanyl initiation in Australian clinical practice. European journal of clinical pharmacology 75 (3) (2018)
Samanta Lalic, Jenni Ilomäki, J Simon Bell, Maarit Jaana Korhonen, Natasa Gisev
Prevalence and incidence of prescription opioid analgesic use in Australia. British journal of clinical pharmacology 85 (1) (2018)
Natasa Gisev, Sallie-Anne Pearson, Emily Aspasia Karanges, Briony Larance, Nicholas Alan Buckley, Sarah Larney, Timothy A Dobbins, Bianca Blanch, Louisa Degenhardt
To what extent do data from pharmaceutical claims under-estimate opioid analgesic utilisation in Australia? Pharmacoepidemiology and drug safety 27 (5) (2017)